+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sanofi S.A. - logo

Sanofi is a global life sciences company committed to improving access to healthcare. From prevention to treatment, Sanofi provides healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. It has a presence in more than 100 countries and industrial sites in more than 40 countries. Sanofi has its headquarters in Paris, France.

Peanut Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Global Big Pharma Partnering Terms and Agreements 2020-2024 - Product Thumbnail Image

Global Big Pharma Partnering Terms and Agreements 2020-2024

  • Report
  • October 2024
  • 2000 Pages
  • Global
From
Meningococcal Vaccines Market Size, Share & Trends Analysis Report By Brand (Menactra, Menveo), By Type, By Serotype, By Age Group, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Meningococcal Vaccines Market Size, Share & Trends Analysis Report By Brand (Menactra, Menveo), By Type, By Serotype, By Age Group, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • May 2023
  • 163 Pages
  • Global
From
Enzymes - Global Strategic Business Report - Product Thumbnail Image

Enzymes - Global Strategic Business Report

  • Report
  • June 2025
  • 153 Pages
  • Global
From
Liver Diseases Therapeutics Market by Disease Type, Therapy Type, Drug Class, Route of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Thumbnail Image

Liver Diseases Therapeutics Market by Disease Type, Therapy Type, Drug Class, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 191 Pages
  • Global
From
Liver Fibrosis Drugs Market by Drug Class, Mechanism of Action, Route of Administration, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Liver Fibrosis Drugs Market by Drug Class, Mechanism of Action, Route of Administration, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 198 Pages
  • Global
From
Skin Antiseptic Products Market by Product Form, Active Ingredient, End User, Distribution Channel, Application - Global Forecast to 2030 - Product Thumbnail Image

Skin Antiseptic Products Market by Product Form, Active Ingredient, End User, Distribution Channel, Application - Global Forecast to 2030

  • Report
  • May 2025
  • 193 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 179 Pages
  • Global
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • September 2022
  • 1353 Pages
  • Global
From
Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Thumbnail Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • June 2025
  • 92 Pages
  • Global
From
Focal Segmental Glomerulosclerosis Market by Drug Class, Stage, End-Use, Patient Type - Global Forecast to 2030 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis Market by Drug Class, Stage, End-Use, Patient Type - Global Forecast to 2030

  • Report
  • May 2025
  • 183 Pages
  • Global
From
Alport Syndrome Market by Treatment Type, End User, Distribution Channel, Patient Age Group, Disease Stage, Insurance Type - Global Forecast to 2030 - Product Thumbnail Image

Alport Syndrome Market by Treatment Type, End User, Distribution Channel, Patient Age Group, Disease Stage, Insurance Type - Global Forecast to 2030

  • Report
  • May 2025
  • 181 Pages
  • Global
From
Hemoglobinopathies Market Size, Share & Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease, Other Hemoglobin (Hb) Variants), By Diagnosis, By Therapy, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Hemoglobinopathies Market Size, Share & Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease, Other Hemoglobin (Hb) Variants), By Diagnosis, By Therapy, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 150 Pages
  • Global
From
Scleroderma Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Scleroderma Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market Report 2025 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Polycystic Kidney Disease Drugs Market 2024-2028 - Product Thumbnail Image

Polycystic Kidney Disease Drugs Market 2024-2028

  • Report
  • July 2024
  • 141 Pages
  • Global
From
Over-The-Counter Consumer Health Products Market by Type, Disease/Disorder Type, Formulation Type, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Over-The-Counter Consumer Health Products Market by Type, Disease/Disorder Type, Formulation Type, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 181 Pages
  • Global
From
Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 183 Pages
  • Global
From
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • March 2024
  • 89 Pages
  • Global
From
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Forecast to 2029 - Product Thumbnail Image

Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Forecast to 2029

  • Report
  • May 2024
  • 535 Pages
  • Global
From
Loading Indicator